The government plans to establish 435 clinical research centers by 2028, aiming to generate $3.8 billion in revenue from clinical trial activities. This initiative was discussed at the Nigeria Economic Summit during a panel session led by Abdu Muktar, the National Coordinator of the Presidential Unlocking Healthcare Value Chain Initiative.
Muktar mentioned that the investment required for setting up these centers is approximately $770 million, with locations already identified by the government. Discussions are ongoing with Contract Research Organizations to ensure demand once the centers are operational.
The goal is to create a substantial revenue stream and job opportunities through these clinical trial activities. Additionally, progress in genomic research was highlighted, including the launch of a major international genomic center in Ede, Osun State.
The government is also working on a single platform for pooled procurement of healthcare products to lower costs and improve access to essential medicines. This initiative is being developed through a Public-Private Partnership framework, adapting successful international models to suit Nigeria’s needs.
Furthermore, there is optimism about the growth of clinical trial activities in Nigeria and Africa, driven by international calls for increased African representation in research. The Nigerian government has a strategy in place to enhance the clinical trial ecosystem, although the potential for drug discovery depends on funding for preclinical research.